Open Access

Inhibition of LHX2 by miR‑124 suppresses cellular migration and invasion in non‑small cell lung cancer

  • Authors:
    • Qinghui Yang
    • Liang Wan
    • Can Xiao
    • Haibo Hu
    • Longqiang  Wang
    • Jun Zhao
    • Zhe Lei
    • Hong‑Tao Zhang
  • View Affiliations

  • Published online on: July 18, 2017     https://doi.org/10.3892/ol.2017.6607
  • Pages: 3429-3436
  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Downregulated microRNA (miR)‑124 is common in numerous types of cancer, including non‑small cell lung cancer (NSCLC). A previous study by the authors demonstrated that LIM‑homeobox domain 2 (LHX2) was upregulated and promoted cell growth in NSCLC. However, whether LHX2 affects the migratory and invasive abilities of NSCLC cells and the association of LHX2 with miR‑124 remains unclear. The present study revealed that miR‑124 expression was frequently decreased in human NSCLC cells and tissues and negatively correlated with LHX2 expression, which was increased in NSCLC cells and tissues. Furthermore, the transfection of miR‑124 mimic significantly inhibited endogenous expression of LHX2 mRNA and protein in A549 and H1299 cells, and miR‑124 inhibitor promoted LHX2 expression. Of note, overexpression of miR‑124 in A549 and H1299 cells attenuated cellular migratory and invasive abilities, and this was observed in LHX2‑silenced A549 and H1299 cells. Knockdown of miR‑124 augmented the migratory and invasive abilities in A549 and H1299 cells. The 3'‑untranslated region of LHX2 transcript has also been identified to be a putative target of miR‑124. Taken together, the results revealed that miR‑124 may inhibit migration and invasion by repressing LHX2 expression in NSCLC cells. The findings of the present study suggested that overexpression of miR‑124 or silencing of LHX2 may provide a therapeutic strategy for advanced NSCLC.
View Figures
View References

Related Articles

Journal Cover

September-2017
Volume 14 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yang Q, Wan L, Xiao C, Hu H, Wang L, Zhao J, Lei Z and Zhang HT: Inhibition of LHX2 by miR‑124 suppresses cellular migration and invasion in non‑small cell lung cancer. Oncol Lett 14: 3429-3436, 2017
APA
Yang, Q., Wan, L., Xiao, C., Hu, H., Wang, L., Zhao, J. ... Zhang, H. (2017). Inhibition of LHX2 by miR‑124 suppresses cellular migration and invasion in non‑small cell lung cancer. Oncology Letters, 14, 3429-3436. https://doi.org/10.3892/ol.2017.6607
MLA
Yang, Q., Wan, L., Xiao, C., Hu, H., Wang, L., Zhao, J., Lei, Z., Zhang, H."Inhibition of LHX2 by miR‑124 suppresses cellular migration and invasion in non‑small cell lung cancer". Oncology Letters 14.3 (2017): 3429-3436.
Chicago
Yang, Q., Wan, L., Xiao, C., Hu, H., Wang, L., Zhao, J., Lei, Z., Zhang, H."Inhibition of LHX2 by miR‑124 suppresses cellular migration and invasion in non‑small cell lung cancer". Oncology Letters 14, no. 3 (2017): 3429-3436. https://doi.org/10.3892/ol.2017.6607